*001663471
*00520190107141007.0
*007ta
*008140730s2010    no#           000 0 eng
*00901186cam a2200325 c 4500
*015  $a1016058$2nbf
*019  $bl
*020  $a9788230816134$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)991024009464702201
*035  $a(NO-LaBS)14435798(bibid)
*035  $a(NO-TrBIB)102400946
*035  $a102400946-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aWE 555
*08274$a616.74$qNO-OsNB$25/nor
*1001 $aHelgeland, Geir$0(NO-TrBIB)10078680$4aut$_95175800
*24510$aMyasthenia gravis ; cytotoxic potential of human sera in vitro and novel non-antibody, disease-modifying factors$cGeir Helgeland
*260  $a[Bergen]$bUniversity of Bergen$c2010
*300  $a1 b. (flere pag.)$bill.
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2010
*650 2$aMyasthenia Gravis$_34801300
*7102 $aUniversitetet i Bergen$bInstitutt for klinisk medisin$0(NO-TrBIB)10074889$4dgg$_20597700
*7760 $tMyasthenia gravis : cytotoxic potential of human sera in vitro and novel non-antibody, disease-modifying factors$w991105337044702201
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:991024009464702202$b2021-11-14T20:39:50Z$z991024009464702202
^